# Coptis (Coptis chinensis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/coptis
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 8 / 10
**Category:** Traditional Chinese Medicine
**Also Known As:** Coptis chinensis, Huang Lian, Chinese Goldthread, Coptidis Rhizoma, Golden Thread, Chinese Coptis, Huanglian

## Overview

Coptis chinensis is a traditional Chinese medicinal herb containing berberine as its primary bioactive alkaloid. Berberine exhibits anti-inflammatory and [hepatoprotective](/ingredients/condition/detox) effects by inhibiting [pro-inflammatory cytokine](/ingredients/condition/inflammation)s and modulating liver enzyme activity.

## Health Benefits

• Anti-inflammatory effects demonstrated in animal models of arthritis through inhibition of cytokines (IL-1β, TNF-α, IL-6) and [inflammatory pathway](/ingredients/condition/inflammation)s (evidence: preliminary/animal studies)
• Liver protective effects shown in rat cholestasis models with reduced liver enzymes (ALT, AST) and bilirubin comparable to ursodeoxycholic acid (evidence: preliminary/animal studies)
• Traditional use for digestive disorders including diarrhea, colitis, and vomiting spanning over 2,000 years in TCM (evidence: traditional/historical use only)
• [Antioxidant activity](/ingredients/condition/antioxidant) through reduction of ROS and increased GSH/SOD levels in preclinical models (evidence: preliminary/in vitro studies)
• Potential [antimicrobial](/ingredients/condition/immune-support) effects traditionally used for respiratory infections and fever, though lacking modern clinical validation (evidence: traditional use only)

## Mechanism of Action

Berberine, the main alkaloid in Coptis chinensis, inhibits nuclear factor-kappa B (NF-κB) signaling pathways, reducing production of [inflammatory](/ingredients/condition/inflammation) cytokines including IL-1β, TNF-α, and IL-6. The compound also modulates liver enzyme activity by protecting hepatocytes from [oxidative stress](/ingredients/condition/antioxidant) and reducing inflammatory cascade activation. Berberine additionally affects AMPK (adenosine monophosphate-activated protein kinase) pathways, contributing to its [hepatoprotective](/ingredients/condition/detox) mechanisms.

## Clinical Summary

Current evidence for Coptis chinensis comes primarily from animal studies rather than human clinical trials. Rat models of arthritis showed significant reductions in [inflammatory](/ingredients/condition/inflammation) markers when treated with Coptis extracts. Cholestasis studies in rats demonstrated decreased liver enzymes (ALT and AST) and reduced bilirubin levels compared to control groups. Human clinical data remains limited, with most research focusing on berberine as an isolated compound rather than whole Coptis preparations.

## Nutritional Profile

Coptis chinensis (Huang Lian) is utilized as a medicinal herb rather than a food source, so conventional macronutrient profiling (carbohydrates, fats, protein) is not clinically relevant at typical therapeutic doses (1.5–10 g dried rhizome/day in traditional practice). Its pharmacological value derives from its rich alkaloid and bioactive compound content:

**Primary Bioactive Alkaloids (collectively 5–8% of dried rhizome weight):**
• Berberine: 4.0–7.5% of dried rhizome (the dominant and most studied alkaloid; typical concentrations ~50–90 mg/g depending on cultivar, harvest time, and processing)
• Coptisine: 0.5–2.0% of dried rhizome
• Palmatine: 0.5–1.5% of dried rhizome
• Jatrorrhizine: 0.2–0.8% of dried rhizome
• Epiberberine: 0.3–1.0% of dried rhizome
• Columbamine: trace to 0.3%
• Magnoflorine: trace amounts

**Other Bioactive Compounds:**
• Ferulic acid and other phenolic acids (minor amounts)
• Lignans (woorenoside, etc.): trace quantities
• Polysaccharides: present in the rhizome matrix, though not well-quantified for [immunomodulatory](/ingredients/condition/immune-support) activity
• Organic acids including chlorogenic acid: trace amounts
• Small amounts of volatile oils

**Mineral Content (approximate, per dried rhizome):**
• Potassium, calcium, magnesium, iron, manganese, and zinc are present in small quantities typical of plant rhizomes, but are not considered nutritionally significant at medicinal doses

**Fiber & Carbohydrates:**
• Crude fiber and starch are present in the dried rhizome but are not relevant at therapeutic doses

**Bioavailability Notes:**
• Berberine has notoriously low oral bioavailability (~5% or less in humans) due to extensive first-pass [metabolism](/ingredients/condition/weight-management) by CYP2D6, CYP1A2, and CYP3A4, poor intestinal absorption, and P-glycoprotein-mediated efflux
• Gut microbiota convert berberine to dihydroberberine in the intestinal lumen, which is absorbed ~5-fold more efficiently and then re-oxidized to berberine in enterocytes
• Berberine undergoes significant enterohepatic recirculation, which extends its effective half-life
• Co-administration with P-glycoprotein inhibitors or lipid-based formulations can enhance berberine bioavailability
• Coptisine and palmatine share similar bioavailability challenges as isoquinoline alkaloids
• Traditional decoction preparation (boiling in water for 15–30 minutes) efficiently extracts water-soluble alkaloids; berberine extraction yield increases with decoction time up to a plateau
• The Chinese Pharmacopoeia (2020 edition) requires a minimum berberine hydrochloride content of 5.5% in quality Coptis chinensis rhizome

## Dosage & Preparation

No clinically studied dosage ranges for human use are available. Animal studies used varying doses showing dose-dependent effects, but human equivalents are not specified. Traditional forms include decoctions or powders without standardized dosing. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Coptis chinensis is generally well-tolerated but can cause gastrointestinal upset including nausea and diarrhea at higher doses. Berberine may interact with medications metabolized by cytochrome P450 enzymes, particularly affecting blood sugar medications and increasing hypoglycemia risk. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals taking anticoagulant medications should consult healthcare providers as berberine may enhance blood-thinning effects.

## Scientific Research

Current research on Coptis chinensis lacks human clinical trials, RCTs, or meta-analyses, with evidence limited to preclinical studies in cell cultures and animal models. Animal studies demonstrate [anti-inflammatory](/ingredients/condition/inflammation) and [hepatoprotective](/ingredients/condition/detox) effects, but no PubMed PMIDs for human trials are available in the current research.

## Historical & Cultural Context

In Traditional Chinese Medicine, Coptis chinensis rhizome (Huang Lian) has been used for over 2,000 years since Shennong's Classic of Materia Medica (Han Dynasty) to clear heat, dry dampness, and detoxify. Featured in over 32,000 TCM formulas, it traditionally treats [inflammatory](/ingredients/condition/inflammation) disorders, digestive issues, skin conditions, and pediatric hyperthermia.

## Synergistic Combinations

Evodia rutaecarpa, Ginger, Scutellaria baicalensis, Phellodendron amurense, Gardenia jasminoides

## Frequently Asked Questions

### Does Coptis chinensis reduce inflammation?

Preliminary animal studies suggest Coptis chinensis may reduce inflammation through its primary alkaloid, berberine, which inhibits NF-κB signaling pathways and suppresses pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6. Anti-inflammatory effects have been demonstrated in animal models of arthritis. However, no human clinical trials currently validate these findings in people. While the mechanistic evidence is promising, it is premature to recommend Coptis chinensis specifically for inflammatory conditions until robust human studies are conducted.

### Can Coptis chinensis protect the liver?

Animal research, particularly in rat cholestasis models, suggests berberine from Coptis chinensis may protect the liver by reducing elevated liver enzymes (ALT, AST) and bilirubin levels, with effects reportedly comparable to ursodeoxycholic acid. The proposed mechanism involves AMPK pathway modulation, protection of hepatocytes from oxidative stress, and reduction of inflammatory cascades. These findings are limited to preclinical studies, and no human clinical trials currently confirm liver-protective effects in people.

### What is Coptis chinensis traditionally used for in TCM?

In Traditional Chinese Medicine, Coptis chinensis has been used for over 2,000 years primarily for digestive complaints including diarrhea, colitis, and vomiting. It has also been traditionally employed for respiratory infections and fever due to its perceived antimicrobial and heat-clearing properties. These applications are based on historical and traditional use rather than modern clinical evidence, and current scientific research has not yet validated most of these traditional indications through rigorous human trials.

### Does Coptis chinensis have antioxidant properties?

In vitro and preclinical studies indicate that berberine, the main bioactive alkaloid in Coptis chinensis, exhibits antioxidant activity by reducing reactive oxygen species (ROS) and increasing levels of antioxidant enzymes including glutathione (GSH) and superoxide dismutase (SOD). These effects have been observed in cell culture and animal models. However, antioxidant benefits in humans have not been confirmed through clinical trials, so conclusions about meaningful antioxidant effects in people cannot yet be drawn.

### Is Coptis chinensis safe to take long-term?

Long-term safety data for Coptis chinensis in humans is lacking, as current research is limited to preclinical animal and in vitro studies without human clinical trials. Berberine, its primary alkaloid, is known to interact with various medications and physiological pathways, including those governing blood pressure and blood sugar. Without established human dosage guidelines or long-term safety studies, prolonged use carries unknown risks. Always consult a qualified healthcare provider before using Coptis chinensis continuously or in any therapeutic capacity.

### Can I take Coptis chinensis if I have a digestive condition?

Coptis chinensis has a long history in Traditional Chinese Medicine for digestive complaints such as diarrhea and colitis, but modern clinical evidence supporting its use in humans with digestive conditions is currently absent. Berberine, its key compound, does show antimicrobial and anti-inflammatory properties in preclinical models that could theoretically benefit gut health. However, without human clinical trials confirming efficacy and safety for specific digestive conditions, it is important to consult a gastroenterologist or healthcare provider before using this herb therapeutically.

### Does Coptis chinensis interact with any medications?

Coptis chinensis contains berberine, which is known to affect multiple biological pathways including AMPK signaling, NF-κB, and potentially drug-metabolising enzymes such as CYP450. This raises the possibility of interactions with medications metabolised by these pathways, including blood thinners, immunosuppressants, and diabetes medications. While the ingredient context notes caution with blood pressure medications specifically, the broader interaction profile of berberine warrants careful review. Always disclose Coptis chinensis use to your healthcare provider, especially if you take prescription medications.

### Is Coptis chinensis the same as berberine supplements?

Coptis chinensis is not the same as isolated berberine supplements, though berberine is its primary active alkaloid and largely responsible for its studied effects. Coptis chinensis is a whole herb containing multiple alkaloids alongside berberine, whereas commercial berberine supplements deliver a purified, standardised compound. Dosage, bioavailability, and safety profiles may differ between the whole herb and isolated berberine. Most modern clinical research on metabolic and anti-inflammatory effects has been conducted using purified berberine, not Coptis chinensis extracts directly.

### What is the active compound in Coptis chinensis?

Berberine is the primary bioactive alkaloid in Coptis chinensis, typically comprising 0.5-2% of the dried root weight. Other alkaloids include coptisine, palmatine, and jatrorrhizine, but berberine provides the main therapeutic effects.

### How much Coptis chinensis should I take daily?

Traditional Chinese medicine typically uses 3-10 grams of dried Coptis root daily, though standardized extracts vary widely in concentration. Most studies use berberine doses of 500-1500mg daily divided into 2-3 doses with meals.

### Can Coptis chinensis help with diabetes?

Animal studies suggest berberine in Coptis may help regulate blood sugar by activating AMPK pathways and improving insulin sensitivity. However, human clinical trials specifically using Coptis chinensis for diabetes are limited compared to isolated berberine research.

### Is Coptis chinensis safe with blood pressure medications?

Coptis chinensis may interact with blood pressure medications as berberine can affect cardiovascular function and drug metabolism. Consultation with a healthcare provider is recommended before combining with antihypertensive drugs or other prescription medications.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*